Atheneos Capital
Atheneos Capital’s goal is to enable rapid ROI in life science focused investments to all stakeholders in such investments. This will be achieved by combining entrepreneur managed funding of high quality early stage projects to build and sell ultra microcap companies (investorpreneurship) that employ cost effective product development (distributed development) with risk managed investments.
Milestones
Investments
| Company |
Date |
Round |
Size |
Participants |
| Altheos | 4/10 | Series A | $20M | 5 |
Videos
Sources
-
Glaucoma drug focus inspires $20M A round for Altheos (fiercebiotech.com)
[edit]
